| Rethinking IL-6 and CRP: Why they are more than inflammatory biomarkers, and why it matters |
65 |
| Neuroprotective effects of fecal microbiota transplantation on MPTP-induced Parkinson's disease mice: Gut microbiota, glial reaction and TLRLI/TNF-alpha signaling pathway |
50 |
| Metformin treatment prevents amyloid plaque deposition and memory impairment in APP/PS1 mice |
45 |
| Antibiotic-induced microbiota perturbation causes gut endocannabinoidome changes, hippocampal neuroglial reorganization and depression in mice |
44 |
| Markers of central inflammation in major depressive disorder: A systematic review and meta-analysis of studies examining cerebrospinal fluid, positron emission tomography and post-mortem brain tissue |
40 |
| Alteration of the fecal microbiota in Chinese patients with Parkinson's disease |
33 |
| Brain glial activation in fibromyalgia - A multi-site positron emission tomography investigation |
32 |
| Altered microbiomes distinguish Alzheimer's disease from amnestic mild cognitive impairment and health in a Chinese cohort |
30 |
| Sex differences in the neuro-immune consequences of stress: Focus on depression and anxiety |
28 |
| Differential immune responses and microbiota profiles in children with autism spectrum disorders and co-morbid gastrointestinal symptoms |
27 |
| Gut microbiota composition in patients with newly diagnosed bipolar disorder and their unaffected first-degree relatives |
26 |
| The influence of neuroinflammation in Autism Spectrum Disorder |
26 |
| Depression and sterile inflammation: Essential role of danger associated molecular patterns |
25 |
| Effects of obesity on depression: A role for inflammation and the gut microbiota |
24 |
| TNF alpha, disrupts blood brain barrier integrity to maintain prolonged depressive-like behavior in mice |
24 |
| Evidence that NLRC4 inflammasome mediates apoptotic and pyroptotic microglial death following ischemic stroke |
24 |
| Large-scale study of Toxoplasma and Cytomegalovirus shows an association between infection and serious psychiatric disorders |
23 |
| Peripheral immune cells infiltrate into sites of secondary neurodegeneration after ischemic stroke |
22 |
| Association between a functional interleukin 6 receptor genetic variant and risk of depression and psychosis in a population-based birth cohort |
21 |
| The beta 2-adrenergic receptor controls inflammation by driving rapid IL-10 secretion |
21 |
| Selective activation of cannabinoid receptor-2 reduces neuroinflammation after traumatic brain injury via alternative macrophage polarization |
21 |
| Effects of SSRIs on peripheral inflammatory markers in patients with major depressive disorder: A systematic review and meta-analysis |
20 |
| Resilience and immunity |
20 |
| Dietary n-3 long chain PUFA supplementation promotes a pro-resolving oxylipin profile in the brain |
19 |
| The concerted amyloid-beta clearance of LRP1 and ABCB1/P-gp across the blood-brain barrier is linked by PICALM |
19 |
| Childhood adversity impact on gut microbiota and inflammatory response to stress during pregnancy |
19 |
| Heart rate variability and inflammation: A meta-analysis of human studies |
19 |
| Innate immunity in the postmortem brain of depressed and suicide subjects: Role of Toll-like receptors |
18 |
| High Mobility Group Box 1 is a novel pathogenic factor and a mechanistic biomarker for epilepsy |
18 |
| Childhood victimization and inflammation in young adulthood: A genetically sensitive cohort study |
18 |
| Dietary patterns, body mass index and inflammation: Pathways to depression and mental health problems in adolescents |
18 |
| Replication and reproducibility issues in the relationship between C-reactive protein and depression: A systematic review and focused meta-analysis |
18 |
| Vagal afferent activation suppresses systemic inflammation via the splanchnic anti-inflammatory pathway |
18 |
| Dysbiosis of microbiome and probiotic treatment in a genetic model of autism spectrum disorders |
17 |
| HMGB1 mediates depressive behavior induced by chronic stress through activating the kynurenine pathway |
17 |
| Profiling inflammatory signatures of schizophrenia: A cross-sectional and meta-analysis study |
17 |
| Th17 cells in depression |
17 |
| Absence of microglial CX3CR1 impairs the synaptic integration of adult-born hippocampal granule neurons |
16 |
| Inflammatory microglia are glycolytic and iron retentive and typify the microglia in APP/PS1 mice |
16 |
| Rh-IFN-alpha attenuates neuroinflammation and improves neurological function by inhibiting NF-kappa B through JAK1-STAT1/TRAF3 pathway in an experimental GMH rat model |
16 |
| Early life stress perturbs the function of microglia in the developing rodent brain: New insights and future challenges |
16 |
| Longitudinal association between inflammatory markers and specific symptoms of depression in a prospective birth cohort |
16 |
| Inflammation and decreased functional connectivity in a widely-distributed network in depression: Centralized effects in the ventral medial prefrontal cortex |
16 |
| Caspase-1 inhibitor exerts brain-protective effects against sepsis-associated encephalopathy and cognitive impairments in a mouse model of sepsis |
16 |
| Spinal interleukin-10 produces antinociception in neuropathy through microglial beta-endorphin expression, separated from antineuroinflammation |
16 |
| A novel role for osteopontin in macrophage-mediated amyloid-beta clearance in Alzheimer's models |
15 |
| Receptor-heteromer mediated regulation of endocannabinoid signaling in activated microglia. Role of CB1 and CB2 receptors and relevance for Alzheimer's disease and levodopa-induced dyskinesia |
15 |
| Probiotics for the treatment of depressive symptoms: An anti-inflammatory mechanism? |
15 |
| Dietary omega-3 deficiency exacerbates inflammation and reveals spatial memory deficits in mice exposed to lipopolysaccharide during gestation |
15 |
| Maternal prenatal depression predicts infant negative affect via maternal inflammatory cytokine levels |
15 |
